CSF2 and Parkinson disease: A neuroprotective effect has also been reported in MPTP and 6‐OHDA PD models, as BDNF production was increased and the expression of apoptosis‐related proteins, such as Bcl 2 and Bax, was reduced after GM‐CSF administration.55